They have been used, for example, to treat depression (Wachtel, 1983; Horowski, 1985) and the related PDE4 inhibitor roflumilast has FDA approval for treatment of symptoms of chronic obstructive pulmonary disorder by oral delivery (Wedzicha et al., 2016). This evidence concerns the gene PDE4A and depressive symptom measurement.